 vanad hyperglycemia mous model non-insulin-depend diabet mellitu effect oral administr vanad insulinomet agent potent inhibitor phosphotyrosyl protein phosphatas ptpase vitro blood glucos ptpase action hyperinsulinem rodent model non-insulin-depend diabet niddm oral administr vanad mg/ml drink water mice wk blood glucos level mg/dl effect bodi weight administr vanad mice similar effect electron microscop examin sign hepatotox treatment slight reduct insulin receptor autophosphoryl antiphosphotyrosin antibodi vivo stimul phosphoryl endogen substrat insulin receptor ob/ob mice cytosol particul ptpase activ liver ob/ob mice dephosphoryl peptid major site insulin receptor autophosphoryl db/db diabet mice ptpase activ cytosol fraction control valu signific differ particul ptpase activ treatment vanad hepat ptpase activ vitro receptor substrat phosphoryl vivo ob/ob mice substanti effect blood glucos data vanad effect oral hypoglycem treatment niddm state major effect distal insulin receptor tyrosin kinas